Figure 3.
Speculative strategy for analyzing CTC-derived organoids in HCC: Patients' blood samples are collected, and CTCs are captured and cultured in situ on a specific chip to form mini organoids. The mini CTC-derived organoids provide in situ observation of cell phenotypes, and the released cells are used for genetic analysis, drug screening, gene editing, and biobanks construction.